KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 180 filers reported holding KARUNA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23 | -23.3% | 138 | 0.0% | 0.00% | – |
| Q2 2023 | $30 | +20.0% | 138 | 0.0% | 0.00% | – |
| Q1 2023 | $25 | -7.4% | 138 | 0.0% | 0.00% | – |
| Q4 2022 | $27 | -99.9% | 138 | +13.1% | 0.00% | – |
| Q3 2022 | $27,000 | +92.9% | 122 | +9.9% | 0.00% | – |
| Q2 2022 | $14,000 | +27.3% | 111 | +29.1% | 0.00% | – |
| Q1 2022 | $11,000 | 0.0% | 86 | 0.0% | 0.00% | – |
| Q4 2021 | $11,000 | -8.3% | 86 | -14.9% | 0.00% | – |
| Q3 2021 | $12,000 | +100.0% | 101 | +87.0% | 0.00% | – |
| Q2 2021 | $6,000 | 0.0% | 54 | 0.0% | 0.00% | – |
| Q1 2021 | $6,000 | +20.0% | 54 | +8.0% | 0.00% | – |
| Q4 2020 | $5,000 | -54.5% | 50 | -66.0% | 0.00% | – |
| Q3 2020 | $11,000 | 0.0% | 147 | 0.0% | 0.00% | – |
| Q2 2020 | $11,000 | 0.0% | 147 | 0.0% | 0.00% | – |
| Q1 2020 | $11,000 | 0.0% | 147 | 0.0% | 0.00% | – |
| Q4 2019 | $11,000 | – | 147 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
| Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
| Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
| First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
| Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
| DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
| Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
| GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
| MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
| Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |